🏷️ LIMITED TIME OFFER: GET 20% OFF GRADE+ YEARLY SUBSCRIPTION →
Log in
HomeClass Notes1,200,000US530,000

BIOL 142 Lecture Notes - Lecture 27: Regulatory Sequence, Tata Box, Rna Splicing

58 views11 pages
bluemosquito338
30 Apr 2018
School
Emory University
Department
Biology
Course
BIOL 142
Professor
Patrick Cafferty

For unlimited access to Class Notes, a Class+ subscription is required.

!"#$"%&'('&% )*%'+,-./)0#$%1'2'%.'1+&-0#)2%#2()&('3%$"-21'3%#2%0"'%4)&/4'40#5'%$"-#2%
6'*).'%#0%6'$)7'3%*+2$0#)2-&8
*''56-$,%$)20.)&%
9:
0.-23&-0#)2-&%$)20.)&%
;:
0.-23$.#40#)2-&%$)20.)&%
<:
4)300.-23$.#40#)2-&%$)20.)&%
=:
posttranslational*control*
E)
A'-.2#21%)6B'$0#('3
1)#Describe#the#role#of#basal#and#regulatory#transcription#factors#in#the#initiation#
of#mRNA#transcription.#
2)#Explain#how#alternative#splicing#results#in#multiple#protein#products#being#
made#from#the#same#eukaryotic#gene.#
3)#Describe#the#role#of#RNA#interference#(RNAi)#in#the#degradation#of#cytoplasmic#
mRNA
<".)7-0#2%7+30%6'%5.-30#$-&&/%.'7)5'&'5%-.)+25%-%0-.1'0%1'2'%0)%-&&)@%0.-23$.#40#)2C
>*%#0%#3%)4'2%-25%&))3'&/%$)74-$0'5?%DE9%4)&/7'.-3'%$-2%6#25%0)%0"'%4.)7)0'.%
-25%5.#('%0.-23$.#40#)2
D'1+&-0#21%0"#3
FG$".)7)3)7'3%H-55#0#)2%)*%7'0"/&%1.)+43%$-2%$-+3'%$)74-$0#)2
E)0%0"'%7-#2%@-/%0)%7)5#*/%1'2'3
I
§
○
J
K)%.'1+&-0'%0"'%-$0#(#0/%)*%3+63'03%)*%1'2'3%#3%acetylation*
Acetyl*groups*are*negatively*charged
Increases*repulsion*of*the*molecules*so*it*doesn't*stay*compact
§
○
J
Histone*deacetylases*(HDACs) .'7)('%-$'0/&%1.)+43%*.)7%"#30)2'3%-25%-&&)@%
$".)7-0#2%$)25'23-0#)2%-25%#3%-33)$#-0'5%@#0"%1'2'%5'-$0#(-0#)2
J
Histone*acetyl*transferases*(HATs) -55%2'1-0#('&/%$"-.1'5%-$'0/&%1.)+43%0)%
4)3#0#('&/%$"-.1'5%"#30)2'%&/3#2'%.'3#5+'3%.'3+&0#21%#2%$".)7-0#2%5'G
$)25'23-0#)2%-25%-&&)@#21%1'2'%'L4.'33#)2C%
D'34)23#6&'%*).%)4'2#21%+4%=E9
○
J
<"'7#$-&%7)5#*#$-0#)23%)2%"#30)2'3%(-.#'3%6'0@''2%$'&&%0/4'3%-25%#3%"'.#0-6&'C%
9$'0/&-0#)2%#3%-2%'C1C%)* epigenetic*inheritance?%#2"'.#0-2$'%2)0%5+'%0)%
5#**'.'2$'3%#2%1'2'%3'M+'2$'3C
='1.''%0)%@"#$"%=E9%#3%-$'0/&-0'5%$-2%6'%4-33'5%*.)7%)2'%1'2'.-0#)2%0)%
0"'%2'L0
○
='1.''%)*%$)74-$0#)2%'**'$03%4"'2)0/4'3%-25%$-2%6'%4-33'5%*.)7%)2'%
1'2'.-0#)2%0)%0"'%2'L0
○
J
1.#Transcription#is#controlled#by#the#interaction#of#regulatory#proteins#with#variable#
regulatory#elements.
NO0'4%P%#2%*#1+.'QJ
R)@%/)+%.'1+&-0'%0.-23$.#40#)2
9%&)0%#2%$)77)2%@#0"%4.),-./)0#$%1'2'%.'1+&-0#)2
○
R-('%4.)7)0'.3%-25%)0"'.%.'1+&-0)./%=E9%3'M+'2$'3%0"-0%1'0%6)+25%6/%
4-.02'.#21%4.)0'#23
○
R-('%'L)23%0"-0%-.'%'L4.'33'5%-25%#20.)23%0"-0%-.'%#20'.('2#21
○
J
9&&%'+,-./)0#$%1'2'3%"-('%-%$)77)2%4.)7)0'.%-25%(-.#-6&'%.'1+&-0)./%'&'7'203
S.)7)0'.%3'M+'2$'3%-.'%$&)3'%0)%0"'%TU%'25%
○
>2%'+,C%S.)7)0'.3?%0"'.'U3%-%"#1"&/%$)23'.('5%3'M+'2$'%$-&&'5%0"'%K9K9%
6)L
○
9&&%4.)7)0'.3%"-('%0"'%K9K9%6)L%-3%-%$)23'.('5%3'M+'2$'
○
J
9&&%'+,-./)0#$%4.)7)0'.3%-.'%6)+25%6/%0"'%K9K9G6#25#21%4.)0'#2%VK;S:%-0%0"'%
K9K9%6)LC%K"'%4.)7)0'.%)$$+.3%-0%0"'%6'1#22#21%)*%0"'%1'2'%-25%#3%0"'%3#0'%
@"'.'%DE9%4)&/7'.-3'%6'1#23%0.-23$.#40#)2
>3%-%K9K9%3'M+'2$'
○
KW>>=%2''53%0)%6#25%0)%0"'%K9K9
>*%/)+%'&#7#2-0'X7+0-0'%K9K9?%KW>>=%$-2U0%6#25%0)%0"'%4.)7)0'.%-25%
#2"#6#03%0.-23$.#40#)2
§
○
J
Promoter-proximal*elements -.'%&)$-0'5%B+30%+430.'-7%)*%0"'%4.)7)0'.%-25%
0"'%0.-23$.#40#)2%30-.0%3#0'%-25%"-('%3'M+'2$'3%+2#M+'%0)%34'$#*#$%1'2'3C
Y2#M+'&/%'+,C
○
K.-23$.#40#)2-&%*-$0).3%@#&&%-&3)%6#25%"'.'
○
K.-23$.#40#)2%*-$0).3%0"-0%@#&&%6#25%5'4'253%)2%@"-0%1'2'%@'U.'%0-&,#21%
-6)+0
○
Z-./%*.)7%1'2'%0)%1'2'%-25%0"'%4.)0'#23%0"-0%@#&&%6#25%0)%0"'7?%-3%
)44)3'5%0)%-&&%'+,%"-(#21%4.)7)0'.3%-25%K9K9%6)L'3
○
Upstream[%0"'%.'1#)2%0)%0"'%TU%'25%)*%-%1'2'
S.)7)0'.%*&-2,3%TU%'25?%@"/%#0U3%$-&&'5%+430.'-7
§
○
Downstream[%0"'%.'1#)2%-0%0"'%\U%'25%)*%-%1'2'
○
J
]+,-./)0#$%1'2'3%"-('%'2"-2$'.3?%4)3#0#('%.'1+&-0)./%$)20.)&%'&'7'203C
Enhancers $-2%6'%&)$-0'5%7).'%0"-2%^__?___%6-3'3%-@-/%*.)7%0"'%4.)7)0'.?%#2%
#20.)23?%).%#2%+2G0.-23$.#6'5%TU%).%\U%*&-2,#21%3'M+'2$'3C%
S)3#0#('%$)20.)&
○
=#**'.'20%'2"-2$'.3%-.'%-33)$#-0'5%@#0"%5#**'.'20%1'2'3C%
○
<-2%6'%*)+25%-2/@"'.'
○
Y430.'-7?%5)@230.'-7?%#23#5'%0"'%1'2'%#2%#20.)23
○
<-2%6'%*-.%-@-/%*.)7%0"'%4.)7)0'.
○
J
9$0#(-0).%4.)0'#23%6#25%enhancers -25%30.)21&/%30#7+&-0'%0"'%0.-23$.#40#)2%
$)74&'LC
J
Silencers?%2'1-0#('%$)20.)&%'&'7'203?%.'4.'33%.-0"'.%0"-2%-$0#(-0'%1'2'%
'L4.'33#)2C%
O#&'2$'.3%6#25%4.)0'#23%$-&&'5%.'4.'33).3%-25%0+.2%)**%0.-23$.#40#)2`0"'/%
"-('%0"'%)44)3#0'%'**'$0%)*%'2"-2$'.3C
○
<-2%6'%('./%*-.%+430.'-7?%5)@230.'-7?%).%#2%0"'%7#55&'%)*%-%1'2'
○
=#**'.3%6/%@"-0%"-44'23%@"'2%-%0.-23$.#40#)2%*-$0).%6#253
○
E'1-0#('%$)20.)&%H@"'2%0.-23$.#40#)2%*-$0).%6#253?%#0%
5)@2.'1+&-0'3X3"+03%5)@2%'L4.'33#)2%)*%0"'%1'2'
○
J
K@)%6.)-5%$&-33'3%)*%4.)0'#23%6#25%0)%.'1+&-0)./%3'M+'2$'3%)*%'+,-./)0#$%1'2'3C
;-3-&%0.-23$.#40#)2%*-$0).3%#20'.-$0%@#0"%0"'%4.)7)0'.%-25%-.'%2)0%.'30.#$0'5%0)%
4-.0#$+&-.%$'&&%0/4'3C%
!"#&'%0"'/%-.'%.'M+#.'5%*).%0.-23$.#40#)2?%0"'/%5)%2)0%.'1+&-0'%1'2'%
'L4.'33#)2C
○
E)0%+2#M+'%0)%3+63'03%)*%1'2'3
○
a'2'.-&%4.)0'#23%2''5'5%*).%'L4.'33#)2
○
b2'%)*%0"'7%#3%WK>>=
W).%'L-74&'?%0"'%6-3-&%0.-23$.#40#)2%*-$0).%KW>>=%6#253%5#.'$0&/%0)%
0"'%K9K9%6)L`KW>>=%-25%)0"'.%4-.02'.%0.-23$.#40#)2%*-$0).3%-.'%
.'M+#.'5%*).%-%&)@%Vc6-3-&d:%&'('&%)*%0.-23$.#40#)2%*.)7%'+,-./)0#$%
1'2'3C
§
9&&%'+,%"-('%K9K9%6)L?%3)%6#25#21%)*%KW>>=%#3%2)0%.'1+&-0)./
E)0%3'&'$0#('I
E)0%3+**#$#'20%*).%*+&&%&'('&3%)*%'L4.'33#)2%*).%1#('2%1'2'3I
E''5'5%*).%0.-23$.#40#)2I
§
○
^C
D'1+&-0)./%0.-23$.#40#)2%*-$0).3%6#25%0)%'2"-2$'.3?%3#&'2$'.3?%-25%4.)7)0'.G
4.)L#7-&%'&'7'203C%
K"'/%-.'%.'34)23#6&'%*).%0"'%'L4.'33#)2%)*%4-.0#$+&-.%1'2'3%#2%4-.0#$+&-.%
$'&&% 0/4'3%-25%-0%4-.0#$+&-.%30-1'3%)*%5'('&)47'20
○
D'34)23#6&'%*).%5'0'.7#2#21%@"-0%#3%'L4.'33'5?%@"'.'?%@"-0%0#7'3?%-0%
@"-0%&'('&3
○
E''5'5%0)%5.#('%'L4.'33#)2%)*%5#**'.'20%1'2'3%#2%5#**'.'20%0#33+'3
○
;#25%0)%'2"-2$'.3?%3#&'2$'.3?%).%4.)7)0'.G4.)L#7-&%'&'7'203
○
PC
eC%K"'%K9K9%6)L%#3%-V2:[%
A.*sequence*common*to*the*promoter*region*of*many*genes.*
;C%3M+-.'G3"-4'5%3'M+'2$'C%
<C%3'M+'2$'%$)77)2%0)%-&&%'2"-2$'.3C%
=C%.'1+&-0)./%3'M+'2$'%2'$'33-./%*).%4.)4'.%0.-23&-0#)2C%
]C%E)2'%)*%0"'%-6)('
=#**'.'20%$'&&%0/4'3%'L4.'33%5#**'.'20%1'2'3%6'$-+3'%0"'/%$)20-#2%5#**'.'20%.'1+&-0)./%
4.)0'#23C
K"'%-$0#(-0#)2%)*%34'$#*#$%.'1+&-0)./%4.)0'#23%6/%'L0.-$'&&+&-.% 3#12-&3%&'-53%0)%
$'.0-#2%4.)0'#23%6'#21%4.)5+$'5%)2&/%#2%$'.0-#2%0/4'3%)*%$'&&3
J
K"'%$+..'20%7)5'&%)*%0.-23$.#40#)2%#2#0#-0#)2%#2%'+,-./)0#$%$'&&3C%VO0'43%^?%P%)*%e:
Regulatory*transcription*factor3%.'$.+#0%$".)7-0#2%.'7)5'&#21%$)74&'L?%).%
R9K3C%<".)7-0#2%5'$)25'23'3C
K)%1'0%'L4.'33#)2%)*%-%1'2'?%#0%"-3%0)%6'%-2%)4'2%$".)7-0#2
○
>*%#0U3%2)0%-&.'-5/%5'G$)25'23'5?%@'U&&%"-('%0)%1'0%-$'0/&%0.-23*'.-3'3%0)%
-$'0/&-0'%=E9%-25%)4'2%+4%0"'%$".)7-0#2
○
DKW3%$-2%"'&4%.'$.+#0%0"'%R9K%0)%@"'.'%)2%0"'%$".)7)3)7'
○
^C
!"'2%$".)7-0#2%5'$)25'23'3?%-%.'1#)2%)*%=E9%#3%'L4)3'5?%#2$&+5#21%0"'%
promoterC
9&&)@3%0.-23$.#40#)2-&%*-$0).3%&#,'%KW>>=%0)%6#25%0)%%$)..'34)25#21%=E9%
3'M+'2$'3%-.)+25%0"'%1'2'
○
;+#&5%$)74&'L%)*%4.)0'#23%2'-.%4.)7)0'.
○
PC
Regulatory*transcription*factors .'$.+#0%4.)0'#23%)*%0"'%6-3-&%0.-23$.#40#)2%
$)74&'L%0)%4.)7)0'.C%
E)0'%&))4#21%=E9
○
R)@%#0%-33'76&'3%-.)+25%0"'%4.)7)0'.
○
]2"-2$'.3%$-2%6'%#2%7-2/%4&-$'3%#2%.'&-0#)2%0)%0"'%4.)7)0'.
R)@%$-2%-%.'1+&-0)./%.'1#)2%6'%*-.%*.)7%0"'%4.)7)0'.%-25%"-(#21%
0"'%'2"-2$'.%6'%'**'$0#('8%>0U3%6'$-+3'%=E9%#3%*&'L#6&'%-25%$-2%&))4%
3)%0"'%KW%6)+25%0)%0"'%'2"-2$'.%$-2%6#25%0)%0"'%$)74&'L%)*%
4.)0'#23%(#-%&))4#21
§
○
\C
RNA*polymerase*II $)74&'0'3%0"'%6-3-&%0.-23$.#40#)2%$)74&'Lf%0.-23$.#40#)2%
6'1#23C
;#253%0)%0.-23$.#40#)2-&%$)74&'L%-25%5.#('3%0.-23$.#40#)2%)*%-%4.'GDE9%
+3#21%$)74&'7'20-./%6-3'%4-#.%.+&'3%0)%0"'%=E9%0'74&-0'
○
eC
TC%>2%0.-23$.#40#)2-&%$)20.)&%#2%'+,-./)0#$%$'&&3[%
9C%-%5#**'.'20%$)76#2-0#)2%)*%=E9%6#25#21%4.)0'#23%V0.-23$.#40#)2-&%*-$0).3:%7-/%
.'1+&-0'%0"'%-$0#(#0/%)*%-%4-.0#$+&-.%1'2'C%
;C%'2"-2$'.3%7-/%6'%#2()&('5%#2%0"'%4.)7)0#)2%-3%@'&&%-3%.'1+&-0#)2%)*%1'2'%
0.-23$.#40#)2C%
<C%KW>>=%#3%.'M+#.'5%*).%6-3-&%&'('&3%)*%0.-23$.#40#)2%)*%7)30%1'2'3C%
=C%'2"-2$'.3%7-/%6'%3)7'%5#30-2$'%*.)7%0"'%4.)7)0'.%3#0'3%0"'/%$)20.)&C
E.*All*of*the*choices*are*correct.*
2.#Alternative#splicing#leads#to#production#of#different#proteins#from#the#same#gene.
NO0'4%\%)*%7)5'&QJ
O4&#$#21%)+0%)*%#20.)23%#2%'+,C%7DE9
g-2/%1'2'3%$)5'%*).%7+&0#4&'%4.)0'#2%4.)5+$03%6'$-+3'%0"'/%5)2U0%
-33)$#-0'%-&&%0"'%'L)23%0)1'0"'.%-&&%0"'%0#7'%#2%-&&%0#33+'3
○
>2%$'.0-#2%4&-$'3?%3)7'%1'2'3%@#&&%)2&/%-33'76&'%3)7'%'L)23%0)%7-,'%-%
4.)0'#2%4.)5+$0?%6+0%-2)0"'.%7-,'3%-%5#**'.'20%4.)5+$0
○
b2'%'+,-./)0#$%1'2'%$-2%$)5'%*).%7+&0#4&'%4.)0'#2%4.)5+$03
○
J
DE9%4.)$'33#21%30'43%N7)5'&%6'&)@Q%H")@%/)+%,2)@%@"'.'%0)%$+0%-25%@"-0%
5)'3%0"'%$+00#21
=-.,%.'1#)23[%'L)23
○
A#1"0%.'1#)23[%#20.)23
○
J
DE9%34&#$#21%.'7)('3%#20.)23%-25%34&#$'3%'L)23%0)1'0"'.C
90%0"'%6)+25-.#'3%6'0@''2%#20.)23%-25%'L)23%-.'%$)23'23+3%3'M+'2$'3[%
"#1"&/%$)23'.('5%3'M+'2$'3%#2%&)03%)*%1'2'3
<)77+2#$-0'%@"'.'%-2%'L)2%#20.)2%6)+25-./%#3%*)+25
§
○
9%37-&&%.#6)2+$&')4.)0'#2%4-.0#$&'%V32DESG hsnerph:%6#253%0)%0"'%
$)23'23+3%3'M+'2$'%-0%0"'%Ti%'L)2H#20.)2%6)+25-./
;#253%0)%3'M+'2$'
§
!"'2%0"'/%#20'.-$0?%0"'/%$-+3'%0"'%#20.)2%0)%&))4%)+0
§
○
92)0"'.%32DES%6#253%2'-.%0"'%\i%'L)2H#20.)2%6)+25-./C
○
J
K"'2%)0"'.%4.)0'#23%6#25%V2)0%4#$0+.'5:?%*).7#21%-%&-.1'%DE9H4.)0'#2%$)74&'L%
$-&&'5%-%34&#$')3)7'C%
K"'%34&#$')3)7'%$)74&'L%$+03%0"'%DE9?%.'&'-3'3% 0"'%#20.)23?%-25%B)#23%0"'%
'253%)*%0"'%'L)23C
E-7'5%-*0'.%*+2$0#)2
§
<-+3'%$+00#21%)*%#20.)2%0)%6'%6.),'2%5)@2%-25%.'$/$&'5
§
32DSO%5#3-33'76&'
§
○
]L)23%B)#2%0)1'0"'.%0)%6'%0.-23&-0'5%#2%0"'%$'&&
○
J
9&0'.2-0#('%34&#$#21%)*%-%34'$#*#$%4.'G7DE9%$-2%1'2'.-0'%5#**'.'20%4.)0'#23%*.)7%-%
3#21&'%1'2'C
9&&)@3%)2'%1'2'%0)%'2$)5'%*).%T%5#**'.'20%4)&/4'40#5'%4.)5+$03%"'.'J
O,'&'0-&%7+3$&'%*+2$0#)2%)*%0.)4)7/)3#2%0'&&3%7+3$&'%0)%$)20.-$0
b2&/%@"-0%0"'7%0)%$)20.-$0%+25'.%$'.0-#2%$#.$+730-2$'3
○
<)20.)&&'5%6/%-%3'.#'3%)*%30'43%0"-0%.'&'-3'%$-&$#+7%#2%0"'%3,'&'0-&%7+3$&'
>2()&('5%#2%4.)$'33%0)%0'&&%7+3$&'%0)%$)20.-$0%@"'2
§
○
J
We*have*less*genes*than*we'd*thought*because*one*gene*can*code*for*many*
products
J
W).%'L-74&'?%$'&&3%#2%*#('%5#**'.'20%0#33+'3%34&#$'%0"'%4.'G7DE9%*).%0"'%7+3$&'%
4.)0'#2%0.)4)7/)3#2%#20)%*#('%5#**'.'20%7DE93C
J
93%-%.'3+&0?%'-$"%)*%*#('%5#**'.'20%0#33+'3%#2%7-77-&3%V3,'&'0-&%7+3$&'?%37))0"%
7+3$&'?%*#6.)6&-30?%&#('.?%-25%6.-#2:%"-3%-%5#**'.'20%*).7%)*%0.)4)7/)3#2
O7))0"%7+3$&'%H)2%0"'%)+03#5'%)*%)+.%6&))5%('33'&3%-25%1+0
○
=#**'.3%#2%30.+$0+.'%#2%5#**'.'20%$'&&% 0/4'3%6/%-33'76&#21%5#**'.'20%3+63'03%
)*%'L)23
○
J
jC%!"#$"%30-0'7'20%-6)+0%DE9%34&#$#21%#3%*-&3'8%DE9%34&#$#21[%9C%.'7)('3%#20.)23C%;C%#3%
4'.*).7'5%6/%37-&&%2+$&'-.%.#6)2+$&')4.)0'#2%4-.0#$&'3%V32DES3:C%<C%-&@-/3%.'7)('3%
0"'%3-7'%'L)23C%=C%#3%5#.'$0'5%6/%$)23'23+3%3'M+'2$'3C%]C%3").0'23%0"'%DE9%7)&'$+&'C
3.#Noncoding#RNAs#are#involved#in#regulating#gene#
NO0'4%e%)*%7DE9%30-6#&#0/QJ
R)@%&#*'34-2%)*%7DE9%#3%.'1+&-0'5J
DE9%#20'.*'.'2$'%VDE9#:%$-2%.'3+&0%#2%.-4#5%7DE9%5'1.-5-0#)2%#2%0"'%$/0)4&-37
DE9%3#&'2$#21%#3%DE9%#20'.*'.'2$'%VDE9#:
R-44'23%#2%2-0+.'?%6+0%-&3)%$-2%'L4'.#7'20-&&/%5)%0"#3%4.)$'33
§
DE9%3#&'2$#21%#3%4-.0%)*%-%3'.#'3%)*%'L4'.#7'20-&%0'$"2#M+'3%@"'.'%
/)+%$-2%,2)$,%5)@2%V&)33%)*%*+2$0#)2%'L4'.#7'20:%0"'%-$0#(#0/%)*%-%
1'2'%-25%&)),%-0%@"-0%4"'2)0/4'%.'3+&03
A'03%/)+%,2)@%@"-0%0"'%1'2'%5)'3I
§
○
DE9%#20'.*'.'2$'%#2()&('3%34'$#*#$%7DE93%6'#21%0-.1'0'5%6/%3#21&'%
30.-25'5%7#$.)DE93%V7#DE93:
○
kP_GP\l%)*%-&&%-2#7-&%-25%4&-20%1'2'3%-.'%.'1+&-0'5%6/%7#DE93C
○
]2$)5'5%*).%6/%0"'#.%)@2%1'2'3
○
=#-1.-7[%7DE9%V/'&&)@:%1'03%0.-23$.#6'5%6/%#03%)@2%1'2'3%7-,#21%-%4.'G
7DE9
>77-0+.'%30-0'%"-3%-%"-#.4#2%&))4
§
b2%'#0"'.%'25?%0"'3'%6-3'3%-.'%$)74&'7'20-./?%3)%6-3'3%*)&5%)2%
#03'&*%-25%$.'-0'3%0"'%&))4
§
K)%@).,%-25%6'%7-0+.'?%-2%'2m/7'%5#$'.%"-3%0)%$+0%0"'%"-#.4#2%&))4
§
A'-53%-%5)+6&'%30.-25'5%7DE9%0"-0%$-2%*#0%#2%-%D>O<
§
○
J
DE9%#20'.*'.'2$'%$-2%.'3+&0%#2%.-4#5%7DE9%5'1.-5-0#)2%#2%0"'%$/0)4&-37C
b2'%)*%0@)%7#DE9%30.-253%1'0%6)+25
○
O0.-25%0"-0%1'03%&'*0%6'"#25%#3%$)74&'7'20-./%0)%-2)0"'.%DE9%#2%0"'%$'&&
○
7#DE9%$-2%4"/3#$-&&/%#20'.-$0%@#0"%0-.1'0%7DE93
○
7DE9%$-2%30#$,%-.)+25%#2%0"'%$)74&'L
<-2U0%6'%0.-23&-0'5
§
n2)$,'5%5)@2%-$0#(#0/%)*%1'2'%0"-0%7-5'%#0
§
○
D>O<%$-2%$+0%0"'%7DE9%#20)%$)74)2'20%4-.03%0)%6'%5'1.-5'5%-25%2)0%
0.-23&-0'5
n2)$,%5)@2%)*%1'2'%-$0#(#0/
§
;#253%0)%3#21&'%30.-25'5%7#DE9
§
○
>*%7DE9%#3%6)+25%0)%$)74&'L%).%6.),'2%5)@2?%1'0%.'5+$0#)2%)*%-$0#(#0/%6/%
1'2'%0"-0%%'2$)5'3%#0
○
J
Eukaryotic+Gene+Regulation+II
W.#5-/?%94.#&%P_?%P_^o
^P[_P%Sg
Unlock document

This preview shows pages 1-3 of the document.
Unlock all 11 pages and 3 million more documents.

Already have an account? Log in
!"#$"%&'('&% )*%'+,-./)0#$%1'2'%.'1+&-0#)2%#2()&('3%$"-21'3%#2%0"'%4)&/4'40#5'%$"-#2%
6'*).'%#0%6'$)7'3%*+2$0#)2-&8
*''56-$,%$)20.)&%9:
0.-23&-0#)2-&%$)20.)&%;:
0.-23$.#40#)2-&%$)20.)&%<:
4)300.-23$.#40#)2-&%$)20.)&%=:
posttranslational*control*E)
>*%/)+%-55%-%2'1-0#('&/%$"-.1'5%4")34"-0'?%-55#21%3)7'0"#21%@#0"%$"-.1'%$"-21'3%#03%
3"-4'%-25%*+2$0#)2
A'-.2#21%)6B'$0#('3
1)#Describe#the#role#of#basal#and#regulatory#transcription#factors#in#the#initiation#
of#mRNA#transcription.#
2)#Explain#how#alternative#splicing#results#in#multiple#protein#products#being#
made#from#the#same#eukaryotic#gene.#
3)#Describe#the#role#of#RNA#interference#(RNAi)#in#the#degradation#of#cytoplasmic#
mRNA
<".)7-0#2%7+30%6'%5.-30#$-&&/%.'7)5'&'5%-.)+25%-%0-.1'0%1'2'%0)%-&&)@%0.-23$.#40#)2C
>*%#0%#3%)4'2%-25%&))3'&/%$)74-$0'5?%DE9%4)&/7'.-3'%$-2%6#25%0)%0"'%4.)7)0'.%
-25%5.#('%0.-23$.#40#)2
D'1+&-0#21%0"#3
FG$".)7)3)7'3%H-55#0#)2%)*%7'0"/&%1.)+43%$-2%$-+3'%$)74-$0#)2
E)0%0"'%7-#2%@-/%0)%7)5#*/%1'2'3I
§
○
J
K)%.'1+&-0'%0"'%-$0#(#0/%)*%3+63'03%)*%1'2'3%#3%acetylation*
Acetyl*groups*are*negatively*charged
Increases*repulsion*of*the*molecules*so*it*doesn't*stay*compact
§
○
J
Histone*deacetylases*(HDACs) .'7)('%-$'0/&%1.)+43%*.)7%"#30)2'3%-25%-&&)@%
$".)7-0#2%$)25'23-0#)2%-25%#3%-33)$#-0'5%@#0"%1'2'%5'-$0#(-0#)2
J
Histone*acetyl*transferases*(HATs) -55%2'1-0#('&/%$"-.1'5%-$'0/&%1.)+43%0)%
4)3#0#('&/%$"-.1'5%"#30)2'%&/3#2'%.'3#5+'3%.'3+&0#21%#2%$".)7-0#2%5'G
$)25'23-0#)2%-25%-&&)@#21%1'2'%'L4.'33#)2C%
D'34)23#6&'%*).%)4'2#21%+4%=E9
○
J
<"'7#$-&%7)5#*#$-0#)23%)2%"#30)2'3%(-.#'3%6'0@''2%$'&&%0/4'3%-25%#3%"'.#0-6&'C%
9$'0/&-0#)2%#3%-2%'C1C%)* epigenetic*inheritance?%#2"'.#0-2$'%2)0%5+'%0)%
5#**'.'2$'3%#2%1'2'%3'M+'2$'3C
='1.''%0)%@"#$"%=E9%#3%-$'0/&-0'5%$-2%6'%4-33'5%*.)7%)2'%1'2'.-0#)2%0)%
0"'%2'L0
○
='1.''%)*%$)74-$0#)2%'**'$03%4"'2)0/4'3%-25%$-2%6'%4-33'5%*.)7%)2'%
1'2'.-0#)2%0)%0"'%2'L0
○
J
1.#Transcription#is#controlled#by#the#interaction#of#regulatory#proteins#with#variable#
regulatory#elements.
NO0'4%P%#2%*#1+.'Q
J
R)@%/)+%.'1+&-0'%0.-23$.#40#)2
9%&)0%#2%$)77)2%@#0"%4.),-./)0#$%1'2'%.'1+&-0#)2
○
R-('%4.)7)0'.3%-25%)0"'.%.'1+&-0)./%=E9%3'M+'2$'3%0"-0%1'0%6)+25%6/%
4-.02'.#21%4.)0'#23
○
R-('%'L)23%0"-0%-.'%'L4.'33'5%-25%#20.)23%0"-0%-.'%#20'.('2#21
○
J
9&&%'+,-./)0#$%1'2'3%"-('%-%$)77)2%4.)7)0'.%-25%(-.#-6&'%.'1+&-0)./%'&'7'203
S.)7)0'.%3'M+'2$'3%-.'%$&)3'%0)%0"'%TU%'25%
○
>2%'+,C%S.)7)0'.3?%0"'.'U3%-%"#1"&/%$)23'.('5%3'M+'2$'%$-&&'5%0"'%K9K9%
6)L
○
9&&%4.)7)0'.3%"-('%0"'%K9K9%6)L%-3%-%$)23'.('5%3'M+'2$'
○
J
9&&%'+,-./)0#$%4.)7)0'.3%-.'%6)+25%6/%0"'%K9K9G6#25#21%4.)0'#2%VK;S:%-0%0"'%
K9K9%6)LC%K"'%4.)7)0'.%)$$+.3%-0%0"'%6'1#22#21%)*%0"'%1'2'%-25%#3%0"'%3#0'%
@"'.'%DE9%4)&/7'.-3'%6'1#23%0.-23$.#40#)2
>3%-%K9K9%3'M+'2$'
○
KW>>=%2''53%0)%6#25%0)%0"'%K9K9
>*%/)+%'&#7#2-0'X7+0-0'%K9K9?%KW>>=%$-2U0%6#25%0)%0"'%4.)7)0'.%-25%
#2"#6#03%0.-23$.#40#)2
§
○
J
Promoter-proximal*elements -.'%&)$-0'5%B+30%+430.'-7%)*%0"'%4.)7)0'.%-25%
0"'%0.-23$.#40#)2%30-.0%3#0'%-25%"-('%3'M+'2$'3%+2#M+'%0)%34'$#*#$%1'2'3C
Y2#M+'&/%'+,C
○
K.-23$.#40#)2-&%*-$0).3%@#&&%-&3)%6#25%"'.'
○
K.-23$.#40#)2%*-$0).3%0"-0%@#&&%6#25%5'4'253%)2%@"-0%1'2'%@'U.'%0-&,#21%
-6)+0
○
Z-./%*.)7%1'2'%0)%1'2'%-25%0"'%4.)0'#23%0"-0%@#&&%6#25%0)%0"'7?%-3%
)44)3'5%0)%-&&%'+,%"-(#21%4.)7)0'.3%-25%K9K9%6)L'3
○
Upstream[%0"'%.'1#)2%0)%0"'%TU%'25%)*%-%1'2'
S.)7)0'.%*&-2,3%TU%'25?%@"/%#0U3%$-&&'5%+430.'-7
§
○
Downstream[%0"'%.'1#)2%-0%0"'%\U%'25%)*%-%1'2'
○
J
]+,-./)0#$%1'2'3%"-('%'2"-2$'.3?%4)3#0#('%.'1+&-0)./%$)20.)&%'&'7'203C
Enhancers $-2%6'%&)$-0'5%7).'%0"-2%^__?___%6-3'3%-@-/%*.)7%0"'%4.)7)0'.?%#2%
#20.)23?%).%#2%+2G0.-23$.#6'5%TU%).%\U%*&-2,#21%3'M+'2$'3C%
S)3#0#('%$)20.)&
○
=#**'.'20%'2"-2$'.3%-.'%-33)$#-0'5%@#0"%5#**'.'20%1'2'3C%
○
<-2%6'%*)+25%-2/@"'.'
○
Y430.'-7?%5)@230.'-7?%#23#5'%0"'%1'2'%#2%#20.)23
○
<-2%6'%*-.%-@-/%*.)7%0"'%4.)7)0'.
○
J
9$0#(-0).%4.)0'#23%6#25%enhancers -25%30.)21&/%30#7+&-0'%0"'%0.-23$.#40#)2%
$)74&'LC
J
Silencers?%2'1-0#('%$)20.)&%'&'7'203?%.'4.'33%.-0"'.%0"-2%-$0#(-0'%1'2'%
'L4.'33#)2C%
O#&'2$'.3%6#25%4.)0'#23%$-&&'5%.'4.'33).3%-25%0+.2%)**%0.-23$.#40#)2`0"'/%
"-('%0"'%)44)3#0'%'**'$0%)*%'2"-2$'.3C
○
<-2%6'%('./%*-.%+430.'-7?%5)@230.'-7?%).%#2%0"'%7#55&'%)*%-%1'2'
○
=#**'.3%6/%@"-0%"-44'23%@"'2%-%0.-23$.#40#)2%*-$0).%6#253
○
E'1-0#('%$)20.)&%H@"'2%0.-23$.#40#)2%*-$0).%6#253?%#0%
5)@2.'1+&-0'3X3"+03%5)@2%'L4.'33#)2%)*%0"'%1'2'
○
J
K@)%6.)-5%$&-33'3%)*%4.)0'#23%6#25%0)%.'1+&-0)./%3'M+'2$'3%)*%'+,-./)0#$%1'2'3C
;-3-&%0.-23$.#40#)2%*-$0).3%#20'.-$0%@#0"%0"'%4.)7)0'.%-25%-.'%2)0%.'30.#$0'5%0)%
4-.0#$+&-.%$'&&%0/4'3C%
!"#&'%0"'/%-.'%.'M+#.'5%*).%0.-23$.#40#)2?%0"'/%5)%2)0%.'1+&-0'%1'2'%
'L4.'33#)2C
○
E)0%+2#M+'%0)%3+63'03%)*%1'2'3
○
a'2'.-&%4.)0'#23%2''5'5%*).%'L4.'33#)2
○
b2'%)*%0"'7%#3%WK>>=
W).%'L-74&'?%0"'%6-3-&%0.-23$.#40#)2%*-$0).%KW>>=%6#253%5#.'$0&/%0)%
0"'%K9K9%6)L`KW>>=%-25%)0"'.%4-.02'.%0.-23$.#40#)2%*-$0).3%-.'%
.'M+#.'5%*).%-%&)@%Vc6-3-&d:%&'('&%)*%0.-23$.#40#)2%*.)7%'+,-./)0#$%
1'2'3C
§
9&&%'+,%"-('%K9K9%6)L?%3)%6#25#21%)*%KW>>=%#3%2)0%.'1+&-0)./
E)0%3'&'$0#('I
E)0%3+**#$#'20%*).%*+&&%&'('&3%)*%'L4.'33#)2%*).%1#('2%1'2'3I
E''5'5%*).%0.-23$.#40#)2I
§
○
^C
D'1+&-0)./%0.-23$.#40#)2%*-$0).3%6#25%0)%'2"-2$'.3?%3#&'2$'.3?%-25%4.)7)0'.G
4.)L#7-&%'&'7'203C%
K"'/%-.'%.'34)23#6&'%*).%0"'%'L4.'33#)2%)*%4-.0#$+&-.%1'2'3%#2%4-.0#$+&-.%
$'&&% 0/4'3%-25%-0%4-.0#$+&-.%30-1'3%)*%5'('&)47'20
○
D'34)23#6&'%*).%5'0'.7#2#21%@"-0%#3%'L4.'33'5?%@"'.'?%@"-0%0#7'3?%-0%
@"-0%&'('&3
○
E''5'5%0)%5.#('%'L4.'33#)2%)*%5#**'.'20%1'2'3%#2%5#**'.'20%0#33+'3
○
;#25%0)%'2"-2$'.3?%3#&'2$'.3?%).%4.)7)0'.G4.)L#7-&%'&'7'203
○
PC
eC%K"'%K9K9%6)L%#3%-V2:[%
A.*sequence*common*to*the*promoter*region*of*many*genes.*
;C%3M+-.'G3"-4'5%3'M+'2$'C%
<C%3'M+'2$'%$)77)2%0)%-&&%'2"-2$'.3C%
=C%.'1+&-0)./%3'M+'2$'%2'$'33-./%*).%4.)4'.%0.-23&-0#)2C%
]C%E)2'%)*%0"'%-6)('
=#**'.'20%$'&&%0/4'3%'L4.'33%5#**'.'20%1'2'3%6'$-+3'%0"'/%$)20-#2%5#**'.'20%.'1+&-0)./%
4.)0'#23C
K"'%-$0#(-0#)2%)*%34'$#*#$%.'1+&-0)./%4.)0'#23%6/%'L0.-$'&&+&-.% 3#12-&3%&'-53%0)%
$'.0-#2%4.)0'#23%6'#21%4.)5+$'5%)2&/%#2%$'.0-#2%0/4'3%)*%$'&&3
J
K"'%$+..'20%7)5'&%)*%0.-23$.#40#)2%#2#0#-0#)2%#2%'+,-./)0#$%$'&&3C%VO0'43%^?%P%)*%e:
Regulatory*transcription*factor3%.'$.+#0%$".)7-0#2%.'7)5'&#21%$)74&'L?%).%
R9K3C%<".)7-0#2%5'$)25'23'3C
K)%1'0%'L4.'33#)2%)*%-%1'2'?%#0%"-3%0)%6'%-2%)4'2%$".)7-0#2
○
>*%#0U3%2)0%-&.'-5/%5'G$)25'23'5?%@'U&&%"-('%0)%1'0%-$'0/&%0.-23*'.-3'3%0)%
-$'0/&-0'%=E9%-25%)4'2%+4%0"'%$".)7-0#2
○
DKW3%$-2%"'&4%.'$.+#0%0"'%R9K%0)%@"'.'%)2%0"'%$".)7)3)7'
○
^C
!"'2%$".)7-0#2%5'$)25'23'3?%-%.'1#)2%)*%=E9%#3%'L4)3'5?%#2$&+5#21%0"'%
promoterC
9&&)@3%0.-23$.#40#)2-&%*-$0).3%&#,'%KW>>=%0)%6#25%0)%%$)..'34)25#21%=E9%
3'M+'2$'3%-.)+25%0"'%1'2'
○
;+#&5%$)74&'L%)*%4.)0'#23%2'-.%4.)7)0'.
○
PC
Regulatory*transcription*factors .'$.+#0%4.)0'#23%)*%0"'%6-3-&%0.-23$.#40#)2%
$)74&'L%0)%4.)7)0'.C%
E)0'%&))4#21%=E9
○
R)@%#0%-33'76&'3%-.)+25%0"'%4.)7)0'.
○
]2"-2$'.3%$-2%6'%#2%7-2/%4&-$'3%#2%.'&-0#)2%0)%0"'%4.)7)0'.
R)@%$-2%-%.'1+&-0)./%.'1#)2%6'%*-.%*.)7%0"'%4.)7)0'.%-25%"-(#21%
0"'%'2"-2$'.%6'%'**'$0#('8%>0U3%6'$-+3'%=E9%#3%*&'L#6&'%-25%$-2%&))4%
3)%0"'%KW%6)+25%0)%0"'%'2"-2$'.%$-2%6#25%0)%0"'%$)74&'L%)*%
4.)0'#23%(#-%&))4#21
§
○
\C
RNA*polymerase*II $)74&'0'3%0"'%6-3-&%0.-23$.#40#)2%$)74&'Lf%0.-23$.#40#)2%
6'1#23C
;#253%0)%0.-23$.#40#)2-&%$)74&'L%-25%5.#('3%0.-23$.#40#)2%)*%-%4.'GDE9%
+3#21%$)74&'7'20-./%6-3'%4-#.%.+&'3%0)%0"'%=E9%0'74&-0'
○
eC
TC%>2%0.-23$.#40#)2-&%$)20.)&%#2%'+,-./)0#$%$'&&3[%
9C%-%5#**'.'20%$)76#2-0#)2%)*%=E9%6#25#21%4.)0'#23%V0.-23$.#40#)2-&%*-$0).3:%7-/%
.'1+&-0'%0"'%-$0#(#0/%)*%-%4-.0#$+&-.%1'2'C%
;C%'2"-2$'.3%7-/%6'%#2()&('5%#2%0"'%4.)7)0#)2%-3%@'&&%-3%.'1+&-0#)2%)*%1'2'%
0.-23$.#40#)2C%
<C%KW>>=%#3%.'M+#.'5%*).%6-3-&%&'('&3%)*%0.-23$.#40#)2%)*%7)30%1'2'3C%
=C%'2"-2$'.3%7-/%6'%3)7'%5#30-2$'%*.)7%0"'%4.)7)0'.%3#0'3%0"'/%$)20.)&C
E.*All*of*the*choices*are*correct.*
2.#Alternative#splicing#leads#to#production#of#different#proteins#from#the#same#gene.
NO0'4%\%)*%7)5'&QJ
O4&#$#21%)+0%)*%#20.)23%#2%'+,C%7DE9
g-2/%1'2'3%$)5'%*).%7+&0#4&'%4.)0'#2%4.)5+$03%6'$-+3'%0"'/%5)2U0%
-33)$#-0'%-&&%0"'%'L)23%0)1'0"'.%-&&%0"'%0#7'%#2%-&&%0#33+'3
○
>2%$'.0-#2%4&-$'3?%3)7'%1'2'3%@#&&%)2&/%-33'76&'%3)7'%'L)23%0)%7-,'%-%
4.)0'#2%4.)5+$0?%6+0%-2)0"'.%7-,'3%-%5#**'.'20%4.)5+$0
○
b2'%'+,-./)0#$%1'2'%$-2%$)5'%*).%7+&0#4&'%4.)0'#2%4.)5+$03
○
J
DE9%4.)$'33#21%30'43%N7)5'&%6'&)@Q%H")@%/)+%,2)@%@"'.'%0)%$+0%-25%@"-0%
5)'3%0"'%$+00#21
=-.,%.'1#)23[%'L)23
○
A#1"0%.'1#)23[%#20.)23
○
J
DE9%34&#$#21%.'7)('3%#20.)23%-25%34&#$'3%'L)23%0)1'0"'.C
90%0"'%6)+25-.#'3%6'0@''2%#20.)23%-25%'L)23%-.'%$)23'23+3%3'M+'2$'3[%
"#1"&/%$)23'.('5%3'M+'2$'3%#2%&)03%)*%1'2'3
<)77+2#$-0'%@"'.'%-2%'L)2%#20.)2%6)+25-./%#3%*)+25
§
○
9%37-&&%.#6)2+$&')4.)0'#2%4-.0#$&'%V32DESG hsnerph:%6#253%0)%0"'%
$)23'23+3%3'M+'2$'%-0%0"'%Ti%'L)2H#20.)2%6)+25-./
;#253%0)%3'M+'2$'
§
!"'2%0"'/%#20'.-$0?%0"'/%$-+3'%0"'%#20.)2%0)%&))4%)+0
§
○
92)0"'.%32DES%6#253%2'-.%0"'%\i%'L)2H#20.)2%6)+25-./C
○
J
K"'2%)0"'.%4.)0'#23%6#25%V2)0%4#$0+.'5:?%*).7#21%-%&-.1'%DE9H4.)0'#2%$)74&'L%
$-&&'5%-%34&#$')3)7'C%
K"'%34&#$')3)7'%$)74&'L%$+03%0"'%DE9?%.'&'-3'3% 0"'%#20.)23?%-25%B)#23%0"'%
'253%)*%0"'%'L)23C
E-7'5%-*0'.%*+2$0#)2
§
<-+3'%$+00#21%)*%#20.)2%0)%6'%6.),'2%5)@2%-25%.'$/$&'5
§
32DSO%5#3-33'76&'
§
○
]L)23%B)#2%0)1'0"'.%0)%6'%0.-23&-0'5%#2%0"'%$'&&
○
J
9&0'.2-0#('%34&#$#21%)*%-%34'$#*#$%4.'G7DE9%$-2%1'2'.-0'%5#**'.'20%4.)0'#23%*.)7%-%
3#21&'%1'2'C
9&&)@3%)2'%1'2'%0)%'2$)5'%*).%T%5#**'.'20%4)&/4'40#5'%4.)5+$03%"'.'J
O,'&'0-&%7+3$&'%*+2$0#)2%)*%0.)4)7/)3#2%0'&&3%7+3$&'%0)%$)20.-$0
b2&/%@"-0%0"'7%0)%$)20.-$0%+25'.%$'.0-#2%$#.$+730-2$'3
○
<)20.)&&'5%6/%-%3'.#'3%)*%30'43%0"-0%.'&'-3'%$-&$#+7%#2%0"'%3,'&'0-&%7+3$&'
>2()&('5%#2%4.)$'33%0)%0'&&%7+3$&'%0)%$)20.-$0%@"'2
§
○
J
We*have*less*genes*than*we'd*thought*because*one*gene*can*code*for*many*
products
J
W).%'L-74&'?%$'&&3%#2%*#('%5#**'.'20%0#33+'3%34&#$'%0"'%4.'G7DE9%*).%0"'%7+3$&'%
4.)0'#2%0.)4)7/)3#2%#20)%*#('%5#**'.'20%7DE93C
J
93%-%.'3+&0?%'-$"%)*%*#('%5#**'.'20%0#33+'3%#2%7-77-&3%V3,'&'0-&%7+3$&'?%37))0"%
7+3$&'?%*#6.)6&-30?%&#('.?%-25%6.-#2:%"-3%-%5#**'.'20%*).7%)*%0.)4)7/)3#2
O7))0"%7+3$&'%H)2%0"'%)+03#5'%)*%)+.%6&))5%('33'&3%-25%1+0
○
=#**'.3%#2%30.+$0+.'%#2%5#**'.'20%$'&&% 0/4'3%6/%-33'76&#21%5#**'.'20%3+63'03%
)*%'L)23
○
J
jC%!"#$"%30-0'7'20%-6)+0%DE9%34&#$#21%#3%*-&3'8%DE9%34&#$#21[%9C%.'7)('3%#20.)23C%;C%#3%
4'.*).7'5%6/%37-&&%2+$&'-.%.#6)2+$&')4.)0'#2%4-.0#$&'3%V32DES3:C%<C%-&@-/3%.'7)('3%
0"'%3-7'%'L)23C%=C%#3%5#.'$0'5%6/%$)23'23+3%3'M+'2$'3C%]C%3").0'23%0"'%DE9%7)&'$+&'C
3.#Noncoding#RNAs#are#involved#in#regulating#gene#
NO0'4%e%)*%7DE9%30-6#&#0/QJ
R)@%&#*'34-2%)*%7DE9%#3%.'1+&-0'5J
DE9%#20'.*'.'2$'%VDE9#:%$-2%.'3+&0%#2%.-4#5%7DE9%5'1.-5-0#)2%#2%0"'%$/0)4&-37
DE9%3#&'2$#21%#3%DE9%#20'.*'.'2$'%VDE9#:
R-44'23%#2%2-0+.'?%6+0%-&3)%$-2%'L4'.#7'20-&&/%5)%0"#3%4.)$'33
§
DE9%3#&'2$#21%#3%4-.0%)*%-%3'.#'3%)*%'L4'.#7'20-&%0'$"2#M+'3%@"'.'%
/)+%$-2%,2)$,%5)@2%V&)33%)*%*+2$0#)2%'L4'.#7'20:%0"'%-$0#(#0/%)*%-%
1'2'%-25%&)),%-0%@"-0%4"'2)0/4'%.'3+&03
A'03%/)+%,2)@%@"-0%0"'%1'2'%5)'3I
§
○
DE9%#20'.*'.'2$'%#2()&('3%34'$#*#$%7DE93%6'#21%0-.1'0'5%6/%3#21&'%
30.-25'5%7#$.)DE93%V7#DE93:
○
kP_GP\l%)*%-&&%-2#7-&%-25%4&-20%1'2'3%-.'%.'1+&-0'5%6/%7#DE93C
○
]2$)5'5%*).%6/%0"'#.%)@2%1'2'3
○
=#-1.-7[%7DE9%V/'&&)@:%1'03%0.-23$.#6'5%6/%#03%)@2%1'2'3%7-,#21%-%4.'G
7DE9
>77-0+.'%30-0'%"-3%-%"-#.4#2%&))4
§
b2%'#0"'.%'25?%0"'3'%6-3'3%-.'%$)74&'7'20-./?%3)%6-3'3%*)&5%)2%
#03'&*%-25%$.'-0'3%0"'%&))4
§
K)%@).,%-25%6'%7-0+.'?%-2%'2m/7'%5#$'.%"-3%0)%$+0%0"'%"-#.4#2%&))4
§
A'-53%-%5)+6&'%30.-25'5%7DE9%0"-0%$-2%*#0%#2%-%D>O<
§
○
J
DE9%#20'.*'.'2$'%$-2%.'3+&0%#2%.-4#5%7DE9%5'1.-5-0#)2%#2%0"'%$/0)4&-37C
b2'%)*%0@)%7#DE9%30.-253%1'0%6)+25
○
O0.-25%0"-0%1'03%&'*0%6'"#25%#3%$)74&'7'20-./%0)%-2)0"'.%DE9%#2%0"'%$'&&
○
7#DE9%$-2%4"/3#$-&&/%#20'.-$0%@#0"%0-.1'0%7DE93
○
7DE9%$-2%30#$,%-.)+25%#2%0"'%$)74&'L
<-2U0%6'%0.-23&-0'5
§
n2)$,'5%5)@2%-$0#(#0/%)*%1'2'%0"-0%7-5'%#0
§
○
D>O<%$-2%$+0%0"'%7DE9%#20)%$)74)2'20%4-.03%0)%6'%5'1.-5'5%-25%2)0%
0.-23&-0'5
n2)$,%5)@2%)*%1'2'%-$0#(#0/
§
;#253%0)%3#21&'%30.-25'5%7#DE9
§
○
>*%7DE9%#3%6)+25%0)%$)74&'L%).%6.),'2%5)@2?%1'0%.'5+$0#)2%)*%-$0#(#0/%6/%
1'2'%0"-0%%'2$)5'3%#0
○
J
Eukaryotic+Gene+Regulation+II
W.#5-/?%94.#&%P_?%P_^o ^P[_P%Sg
Unlock document

This preview shows pages 1-3 of the document.
Unlock all 11 pages and 3 million more documents.

Already have an account? Log in
!"#$"%&'('&% )*%'+,-./)0#$%1'2'%.'1+&-0#)2%#2()&('3%$"-21'3%#2%0"'%4)&/4'40#5'%$"-#2%
6'*).'%#0%6'$)7'3%*+2$0#)2-&8
*''56-$,%$)20.)&%9:
0.-23&-0#)2-&%$)20.)&%;:
0.-23$.#40#)2-&%$)20.)&%<:
4)300.-23$.#40#)2-&%$)20.)&%=:
posttranslational*control*E)
>*%/)+%-55%-%2'1-0#('&/%$"-.1'5%4")34"-0'?%-55#21%3)7'0"#21%@#0"%$"-.1'%$"-21'3%#03%
3"-4'%-25%*+2$0#)2
A'-.2#21%)6B'$0#('3
1)#Describe#the#role#of#basal#and#regulatory#transcription#factors#in#the#initiation#
of#mRNA#transcription.#
2)#Explain#how#alternative#splicing#results#in#multiple#protein#products#being#
made#from#the#same#eukaryotic#gene.#
3)#Describe#the#role#of#RNA#interference#(RNAi)#in#the#degradation#of#cytoplasmic#
mRNA
<".)7-0#2%7+30%6'%5.-30#$-&&/%.'7)5'&'5%-.)+25%-%0-.1'0%1'2'%0)%-&&)@%0.-23$.#40#)2C
>*%#0%#3%)4'2%-25%&))3'&/%$)74-$0'5?%DE9%4)&/7'.-3'%$-2%6#25%0)%0"'%4.)7)0'.%
-25%5.#('%0.-23$.#40#)2
D'1+&-0#21%0"#3
FG$".)7)3)7'3%H-55#0#)2%)*%7'0"/&%1.)+43%$-2%$-+3'%$)74-$0#)2
E)0%0"'%7-#2%@-/%0)%7)5#*/%1'2'3I
§
○
J
K)%.'1+&-0'%0"'%-$0#(#0/%)*%3+63'03%)*%1'2'3%#3%acetylation*
Acetyl*groups*are*negatively*charged
Increases*repulsion*of*the*molecules*so*it*doesn't*stay*compact
§
○
J
Histone*deacetylases*(HDACs) .'7)('%-$'0/&%1.)+43%*.)7%"#30)2'3%-25%-&&)@%
$".)7-0#2%$)25'23-0#)2%-25%#3%-33)$#-0'5%@#0"%1'2'%5'-$0#(-0#)2
J
Histone*acetyl*transferases*(HATs) -55%2'1-0#('&/%$"-.1'5%-$'0/&%1.)+43%0)%
4)3#0#('&/%$"-.1'5%"#30)2'%&/3#2'%.'3#5+'3%.'3+&0#21%#2%$".)7-0#2%5'G
$)25'23-0#)2%-25%-&&)@#21%1'2'%'L4.'33#)2C%
D'34)23#6&'%*).%)4'2#21%+4%=E9
○
J
<"'7#$-&%7)5#*#$-0#)23%)2%"#30)2'3%(-.#'3%6'0@''2%$'&&%0/4'3%-25%#3%"'.#0-6&'C%
9$'0/&-0#)2%#3%-2%'C1C%)* epigenetic*inheritance?%#2"'.#0-2$'%2)0%5+'%0)%
5#**'.'2$'3%#2%1'2'%3'M+'2$'3C
='1.''%0)%@"#$"%=E9%#3%-$'0/&-0'5%$-2%6'%4-33'5%*.)7%)2'%1'2'.-0#)2%0)%
0"'%2'L0
○
='1.''%)*%$)74-$0#)2%'**'$03%4"'2)0/4'3%-25%$-2%6'%4-33'5%*.)7%)2'%
1'2'.-0#)2%0)%0"'%2'L0
○
J
1.#Transcription#is#controlled#by#the#interaction#of#regulatory#proteins#with#variable#
regulatory#elements.
NO0'4%P%#2%*#1+.'QJ
R)@%/)+%.'1+&-0'%0.-23$.#40#)2
9%&)0%#2%$)77)2%@#0"%4.),-./)0#$%1'2'%.'1+&-0#)2
○
R-('%4.)7)0'.3%-25%)0"'.%.'1+&-0)./%=E9%3'M+'2$'3%0"-0%1'0%6)+25%6/%
4-.02'.#21%4.)0'#23
○
R-('%'L)23%0"-0%-.'%'L4.'33'5%-25%#20.)23%0"-0%-.'%#20'.('2#21
○
J
9&&%'+,-./)0#$%1'2'3%"-('%-%$)77)2%4.)7)0'.%-25%(-.#-6&'%.'1+&-0)./%'&'7'203
S.)7)0'.%3'M+'2$'3%-.'%$&)3'%0)%0"'%TU%'25%
○
>2%'+,C%S.)7)0'.3?%0"'.'U3%-%"#1"&/%$)23'.('5%3'M+'2$'%$-&&'5%0"'%K9K9%
6)L
○
9&&%4.)7)0'.3%"-('%0"'%K9K9%6)L%-3%-%$)23'.('5%3'M+'2$'
○
J
9&&%'+,-./)0#$%4.)7)0'.3%-.'%6)+25%6/%0"'%K9K9G6#25#21%4.)0'#2%VK;S:%-0%0"'%
K9K9%6)LC%K"'%4.)7)0'.%)$$+.3%-0%0"'%6'1#22#21%)*%0"'%1'2'%-25%#3%0"'%3#0'%
@"'.'%DE9%4)&/7'.-3'%6'1#23%0.-23$.#40#)2
>3%-%K9K9%3'M+'2$'
○
KW>>=%2''53%0)%6#25%0)%0"'%K9K9
>*%/)+%'&#7#2-0'X7+0-0'%K9K9?%KW>>=%$-2U0%6#25%0)%0"'%4.)7)0'.%-25%
#2"#6#03%0.-23$.#40#)2
§
○
J
Promoter-proximal*elements -.'%&)$-0'5%B+30%+430.'-7%)*%0"'%4.)7)0'.%-25%
0"'%0.-23$.#40#)2%30-.0%3#0'%-25%"-('%3'M+'2$'3%+2#M+'%0)%34'$#*#$%1'2'3C
Y2#M+'&/%'+,C
○
K.-23$.#40#)2-&%*-$0).3%@#&&%-&3)%6#25%"'.'
○
K.-23$.#40#)2%*-$0).3%0"-0%@#&&%6#25%5'4'253%)2%@"-0%1'2'%@'U.'%0-&,#21%
-6)+0
○
Z-./%*.)7%1'2'%0)%1'2'%-25%0"'%4.)0'#23%0"-0%@#&&%6#25%0)%0"'7?%-3%
)44)3'5%0)%-&&%'+,%"-(#21%4.)7)0'.3%-25%K9K9%6)L'3
○
Upstream[%0"'%.'1#)2%0)%0"'%TU%'25%)*%-%1'2'
S.)7)0'.%*&-2,3%TU%'25?%@"/%#0U3%$-&&'5%+430.'-7
§
○
Downstream[%0"'%.'1#)2%-0%0"'%\U%'25%)*%-%1'2'
○
J
]+,-./)0#$%1'2'3%"-('%'2"-2$'.3?%4)3#0#('%.'1+&-0)./%$)20.)&%'&'7'203C
Enhancers $-2%6'%&)$-0'5%7).'%0"-2%^__?___%6-3'3%-@-/%*.)7%0"'%4.)7)0'.?%#2%
#20.)23?%).%#2%+2G0.-23$.#6'5%TU%).%\U%*&-2,#21%3'M+'2$'3C%
S)3#0#('%$)20.)&
○
=#**'.'20%'2"-2$'.3%-.'%-33)$#-0'5%@#0"%5#**'.'20%1'2'3C%
○
<-2%6'%*)+25%-2/@"'.'
○
Y430.'-7?%5)@230.'-7?%#23#5'%0"'%1'2'%#2%#20.)23
○
<-2%6'%*-.%-@-/%*.)7%0"'%4.)7)0'.
○
J
9$0#(-0).%4.)0'#23%6#25%enhancers -25%30.)21&/%30#7+&-0'%0"'%0.-23$.#40#)2%
$)74&'LC
J
Silencers?%2'1-0#('%$)20.)&%'&'7'203?%.'4.'33%.-0"'.%0"-2%-$0#(-0'%1'2'%
'L4.'33#)2C%
O#&'2$'.3%6#25%4.)0'#23%$-&&'5%.'4.'33).3%-25%0+.2%)**%0.-23$.#40#)2`0"'/%
"-('%0"'%)44)3#0'%'**'$0%)*%'2"-2$'.3C
○
<-2%6'%('./%*-.%+430.'-7?%5)@230.'-7?%).%#2%0"'%7#55&'%)*%-%1'2'
○
=#**'.3%6/%@"-0%"-44'23%@"'2%-%0.-23$.#40#)2%*-$0).%6#253
○
E'1-0#('%$)20.)&%H@"'2%0.-23$.#40#)2%*-$0).%6#253?%#0%
5)@2.'1+&-0'3X3"+03%5)@2%'L4.'33#)2%)*%0"'%1'2'
○
J
K@)%6.)-5%$&-33'3%)*%4.)0'#23%6#25%0)%.'1+&-0)./%3'M+'2$'3%)*%'+,-./)0#$%1'2'3C
;-3-&%0.-23$.#40#)2%*-$0).3%#20'.-$0%@#0"%0"'%4.)7)0'.%-25%-.'%2)0%.'30.#$0'5%0)%
4-.0#$+&-.%$'&&%0/4'3C%
!"#&'%0"'/%-.'%.'M+#.'5%*).%0.-23$.#40#)2?%0"'/%5)%2)0%.'1+&-0'%1'2'%
'L4.'33#)2C
○
E)0%+2#M+'%0)%3+63'03%)*%1'2'3
○
a'2'.-&%4.)0'#23%2''5'5%*).%'L4.'33#)2
○
b2'%)*%0"'7%#3%WK>>=
W).%'L-74&'?%0"'%6-3-&%0.-23$.#40#)2%*-$0).%KW>>=%6#253%5#.'$0&/%0)%
0"'%K9K9%6)L`KW>>=%-25%)0"'.%4-.02'.%0.-23$.#40#)2%*-$0).3%-.'%
.'M+#.'5%*).%-%&)@%Vc6-3-&d:%&'('&%)*%0.-23$.#40#)2%*.)7%'+,-./)0#$%
1'2'3C
§
9&&%'+,%"-('%K9K9%6)L?%3)%6#25#21%)*%KW>>=%#3%2)0%.'1+&-0)./
E)0%3'&'$0#('I
E)0%3+**#$#'20%*).%*+&&%&'('&3%)*%'L4.'33#)2%*).%1#('2%1'2'3I
E''5'5%*).%0.-23$.#40#)2I
§
○
^C
D'1+&-0)./%0.-23$.#40#)2%*-$0).3%6#25%0)%'2"-2$'.3?%3#&'2$'.3?%-25%4.)7)0'.G
4.)L#7-&%'&'7'203C%
K"'/%-.'%.'34)23#6&'%*).%0"'%'L4.'33#)2%)*%4-.0#$+&-.%1'2'3%#2%4-.0#$+&-.%
$'&&% 0/4'3%-25%-0%4-.0#$+&-.%30-1'3%)*%5'('&)47'20
○
D'34)23#6&'%*).%5'0'.7#2#21%@"-0%#3%'L4.'33'5?%@"'.'?%@"-0%0#7'3?%-0%
@"-0%&'('&3
○
E''5'5%0)%5.#('%'L4.'33#)2%)*%5#**'.'20%1'2'3%#2%5#**'.'20%0#33+'3
○
;#25%0)%'2"-2$'.3?%3#&'2$'.3?%).%4.)7)0'.G4.)L#7-&%'&'7'203
○
PC
eC%K"'%K9K9%6)L%#3%-V2:[%
A.*sequence*common*to*the*promoter*region*of*many*genes.*
;C%3M+-.'G3"-4'5%3'M+'2$'C%
<C%3'M+'2$'%$)77)2%0)%-&&%'2"-2$'.3C%
=C%.'1+&-0)./%3'M+'2$'%2'$'33-./%*).%4.)4'.%0.-23&-0#)2C%
]C%E)2'%)*%0"'%-6)('
=#**'.'20%$'&&%0/4'3%'L4.'33%5#**'.'20%1'2'3%6'$-+3'%0"'/%$)20-#2%5#**'.'20%.'1+&-0)./%
4.)0'#23C
K"'%-$0#(-0#)2%)*%34'$#*#$%.'1+&-0)./%4.)0'#23%6/%'L0.-$'&&+&-.% 3#12-&3%&'-53%0)%
$'.0-#2%4.)0'#23%6'#21%4.)5+$'5%)2&/%#2%$'.0-#2%0/4'3%)*%$'&&3
J
K"'%$+..'20%7)5'&%)*%0.-23$.#40#)2%#2#0#-0#)2%#2%'+,-./)0#$%$'&&3C%VO0'43%^?%P%)*%e:
Regulatory*transcription*factor3%.'$.+#0%$".)7-0#2%.'7)5'&#21%$)74&'L?%).%
R9K3C%<".)7-0#2%5'$)25'23'3C
K)%1'0%'L4.'33#)2%)*%-%1'2'?%#0%"-3%0)%6'%-2%)4'2%$".)7-0#2
○
>*%#0U3%2)0%-&.'-5/%5'G$)25'23'5?%@'U&&%"-('%0)%1'0%-$'0/&%0.-23*'.-3'3%0)%
-$'0/&-0'%=E9%-25%)4'2%+4%0"'%$".)7-0#2
○
DKW3%$-2%"'&4%.'$.+#0%0"'%R9K%0)%@"'.'%)2%0"'%$".)7)3)7'
○
^C
!"'2%$".)7-0#2%5'$)25'23'3?%-%.'1#)2%)*%=E9%#3%'L4)3'5?%#2$&+5#21%0"'%
promoterC
9&&)@3%0.-23$.#40#)2-&%*-$0).3%&#,'%KW>>=%0)%6#25%0)%%$)..'34)25#21%=E9%
3'M+'2$'3%-.)+25%0"'%1'2'
○
;+#&5%$)74&'L%)*%4.)0'#23%2'-.%4.)7)0'.
○
PC
Regulatory*transcription*factors .'$.+#0%4.)0'#23%)*%0"'%6-3-&%0.-23$.#40#)2%
$)74&'L%0)%4.)7)0'.C%
E)0'%&))4#21%=E9
○
R)@%#0%-33'76&'3%-.)+25%0"'%4.)7)0'.
○
]2"-2$'.3%$-2%6'%#2%7-2/%4&-$'3%#2%.'&-0#)2%0)%0"'%4.)7)0'.
R)@%$-2%-%.'1+&-0)./%.'1#)2%6'%*-.%*.)7%0"'%4.)7)0'.%-25%"-(#21%
0"'%'2"-2$'.%6'%'**'$0#('8%>0U3%6'$-+3'%=E9%#3%*&'L#6&'%-25%$-2%&))4%
3)%0"'%KW%6)+25%0)%0"'%'2"-2$'.%$-2%6#25%0)%0"'%$)74&'L%)*%
4.)0'#23%(#-%&))4#21
§
○
\C
RNA*polymerase*II $)74&'0'3%0"'%6-3-&%0.-23$.#40#)2%$)74&'Lf%0.-23$.#40#)2%
6'1#23C
;#253%0)%0.-23$.#40#)2-&%$)74&'L%-25%5.#('3%0.-23$.#40#)2%)*%-%4.'GDE9%
+3#21%$)74&'7'20-./%6-3'%4-#.%.+&'3%0)%0"'%=E9%0'74&-0'
○
eC
TC%>2%0.-23$.#40#)2-&%$)20.)&%#2%'+,-./)0#$%$'&&3[%
9C%-%5#**'.'20%$)76#2-0#)2%)*%=E9%6#25#21%4.)0'#23%V0.-23$.#40#)2-&%*-$0).3:%7-/%
.'1+&-0'%0"'%-$0#(#0/%)*%-%4-.0#$+&-.%1'2'C%
;C%'2"-2$'.3%7-/%6'%#2()&('5%#2%0"'%4.)7)0#)2%-3%@'&&%-3%.'1+&-0#)2%)*%1'2'%
0.-23$.#40#)2C%
<C%KW>>=%#3%.'M+#.'5%*).%6-3-&%&'('&3%)*%0.-23$.#40#)2%)*%7)30%1'2'3C%
=C%'2"-2$'.3%7-/%6'%3)7'%5#30-2$'%*.)7%0"'%4.)7)0'.%3#0'3%0"'/%$)20.)&C
E.*All*of*the*choices*are*correct.*
2.#Alternative#splicing#leads#to#production#of#different#proteins#from#the#same#gene.
NO0'4%\%)*%7)5'&QJ
O4&#$#21%)+0%)*%#20.)23%#2%'+,C%7DE9
g-2/%1'2'3%$)5'%*).%7+&0#4&'%4.)0'#2%4.)5+$03%6'$-+3'%0"'/%5)2U0%
-33)$#-0'%-&&%0"'%'L)23%0)1'0"'.%-&&%0"'%0#7'%#2%-&&%0#33+'3
○
>2%$'.0-#2%4&-$'3?%3)7'%1'2'3%@#&&%)2&/%-33'76&'%3)7'%'L)23%0)%7-,'%-%
4.)0'#2%4.)5+$0?%6+0%-2)0"'.%7-,'3%-%5#**'.'20%4.)5+$0
○
b2'%'+,-./)0#$%1'2'%$-2%$)5'%*).%7+&0#4&'%4.)0'#2%4.)5+$03
○
J
DE9%4.)$'33#21%30'43%N7)5'&%6'&)@Q%H")@%/)+%,2)@%@"'.'%0)%$+0%-25%@"-0%
5)'3%0"'%$+00#21
=-.,%.'1#)23[%'L)23
○
A#1"0%.'1#)23[%#20.)23
○
J
DE9%34&#$#21%.'7)('3%#20.)23%-25%34&#$'3%'L)23%0)1'0"'.C
90%0"'%6)+25-.#'3%6'0@''2%#20.)23%-25%'L)23%-.'%$)23'23+3%3'M+'2$'3[%
"#1"&/%$)23'.('5%3'M+'2$'3%#2%&)03%)*%1'2'3
<)77+2#$-0'%@"'.'%-2%'L)2%#20.)2%6)+25-./%#3%*)+25
§
○
9%37-&&%.#6)2+$&')4.)0'#2%4-.0#$&'%V32DESG hsnerph:%6#253%0)%0"'%
$)23'23+3%3'M+'2$'%-0%0"'%Ti%'L)2H#20.)2%6)+25-./
;#253%0)%3'M+'2$'
§
!"'2%0"'/%#20'.-$0?%0"'/%$-+3'%0"'%#20.)2%0)%&))4%)+0
§
○
92)0"'.%32DES%6#253%2'-.%0"'%\i%'L)2H#20.)2%6)+25-./C
○
J
K"'2%)0"'.%4.)0'#23%6#25%V2)0%4#$0+.'5:?%*).7#21%-%&-.1'%DE9H4.)0'#2%$)74&'L%
$-&&'5%-%34&#$')3)7'C%
K"'%34&#$')3)7'%$)74&'L%$+03%0"'%DE9?%.'&'-3'3% 0"'%#20.)23?%-25%B)#23%0"'%
'253%)*%0"'%'L)23C
E-7'5%-*0'.%*+2$0#)2
§
<-+3'%$+00#21%)*%#20.)2%0)%6'%6.),'2%5)@2%-25%.'$/$&'5
§
32DSO%5#3-33'76&'
§
○
]L)23%B)#2%0)1'0"'.%0)%6'%0.-23&-0'5%#2%0"'%$'&&
○
J
9&0'.2-0#('%34&#$#21%)*%-%34'$#*#$%4.'G7DE9%$-2%1'2'.-0'%5#**'.'20%4.)0'#23%*.)7%-%
3#21&'%1'2'C
9&&)@3%)2'%1'2'%0)%'2$)5'%*).%T%5#**'.'20%4)&/4'40#5'%4.)5+$03%"'.'J
O,'&'0-&%7+3$&'%*+2$0#)2%)*%0.)4)7/)3#2%0'&&3%7+3$&'%0)%$)20.-$0
b2&/%@"-0%0"'7%0)%$)20.-$0%+25'.%$'.0-#2%$#.$+730-2$'3
○
<)20.)&&'5%6/%-%3'.#'3%)*%30'43%0"-0%.'&'-3'%$-&$#+7%#2%0"'%3,'&'0-&%7+3$&'
>2()&('5%#2%4.)$'33%0)%0'&&%7+3$&'%0)%$)20.-$0%@"'2
§
○
J
We*have*less*genes*than*we'd*thought*because*one*gene*can*code*for*many*
products
J
W).%'L-74&'?%$'&&3%#2%*#('%5#**'.'20%0#33+'3%34&#$'%0"'%4.'G7DE9%*).%0"'%7+3$&'%
4.)0'#2%0.)4)7/)3#2%#20)%*#('%5#**'.'20%7DE93C
J
93%-%.'3+&0?%'-$"%)*%*#('%5#**'.'20%0#33+'3%#2%7-77-&3%V3,'&'0-&%7+3$&'?%37))0"%
7+3$&'?%*#6.)6&-30?%&#('.?%-25%6.-#2:%"-3%-%5#**'.'20%*).7%)*%0.)4)7/)3#2
O7))0"%7+3$&'%H)2%0"'%)+03#5'%)*%)+.%6&))5%('33'&3%-25%1+0
○
=#**'.3%#2%30.+$0+.'%#2%5#**'.'20%$'&&% 0/4'3%6/%-33'76&#21%5#**'.'20%3+63'03%
)*%'L)23
○
J
jC%!"#$"%30-0'7'20%-6)+0%DE9%34&#$#21%#3%*-&3'8%DE9%34&#$#21[%9C%.'7)('3%#20.)23C%;C%#3%
4'.*).7'5%6/%37-&&%2+$&'-.%.#6)2+$&')4.)0'#2%4-.0#$&'3%V32DES3:C%<C%-&@-/3%.'7)('3%
0"'%3-7'%'L)23C%=C%#3%5#.'$0'5%6/%$)23'23+3%3'M+'2$'3C%]C%3").0'23%0"'%DE9%7)&'$+&'C
3.#Noncoding#RNAs#are#involved#in#regulating#gene#
NO0'4%e%)*%7DE9%30-6#&#0/QJ
R)@%&#*'34-2%)*%7DE9%#3%.'1+&-0'5J
DE9%#20'.*'.'2$'%VDE9#:%$-2%.'3+&0%#2%.-4#5%7DE9%5'1.-5-0#)2%#2%0"'%$/0)4&-37
DE9%3#&'2$#21%#3%DE9%#20'.*'.'2$'%VDE9#:
R-44'23%#2%2-0+.'?%6+0%-&3)%$-2%'L4'.#7'20-&&/%5)%0"#3%4.)$'33
§
DE9%3#&'2$#21%#3%4-.0%)*%-%3'.#'3%)*%'L4'.#7'20-&%0'$"2#M+'3%@"'.'%
/)+%$-2%,2)$,%5)@2%V&)33%)*%*+2$0#)2%'L4'.#7'20:%0"'%-$0#(#0/%)*%-%
1'2'%-25%&)),%-0%@"-0%4"'2)0/4'%.'3+&03
A'03%/)+%,2)@%@"-0%0"'%1'2'%5)'3I
§
○
DE9%#20'.*'.'2$'%#2()&('3%34'$#*#$%7DE93%6'#21%0-.1'0'5%6/%3#21&'%
30.-25'5%7#$.)DE93%V7#DE93:
○
kP_GP\l%)*%-&&%-2#7-&%-25%4&-20%1'2'3%-.'%.'1+&-0'5%6/%7#DE93C
○
]2$)5'5%*).%6/%0"'#.%)@2%1'2'3
○
=#-1.-7[%7DE9%V/'&&)@:%1'03%0.-23$.#6'5%6/%#03%)@2%1'2'3%7-,#21%-%4.'G
7DE9
>77-0+.'%30-0'%"-3%-%"-#.4#2%&))4
§
b2%'#0"'.%'25?%0"'3'%6-3'3%-.'%$)74&'7'20-./?%3)%6-3'3%*)&5%)2%
#03'&*%-25%$.'-0'3%0"'%&))4
§
K)%@).,%-25%6'%7-0+.'?%-2%'2m/7'%5#$'.%"-3%0)%$+0%0"'%"-#.4#2%&))4
§
A'-53%-%5)+6&'%30.-25'5%7DE9%0"-0%$-2%*#0%#2%-%D>O<
§
○
J
DE9%#20'.*'.'2$'%$-2%.'3+&0%#2%.-4#5%7DE9%5'1.-5-0#)2%#2%0"'%$/0)4&-37C
b2'%)*%0@)%7#DE9%30.-253%1'0%6)+25
○
O0.-25%0"-0%1'03%&'*0%6'"#25%#3%$)74&'7'20-./%0)%-2)0"'.%DE9%#2%0"'%$'&&
○
7#DE9%$-2%4"/3#$-&&/%#20'.-$0%@#0"%0-.1'0%7DE93
○
7DE9%$-2%30#$,%-.)+25%#2%0"'%$)74&'L
<-2U0%6'%0.-23&-0'5
§
n2)$,'5%5)@2%-$0#(#0/%)*%1'2'%0"-0%7-5'%#0
§
○
D>O<%$-2%$+0%0"'%7DE9%#20)%$)74)2'20%4-.03%0)%6'%5'1.-5'5%-25%2)0%
0.-23&-0'5
n2)$,%5)@2%)*%1'2'%-$0#(#0/
§
;#253%0)%3#21&'%30.-25'5%7#DE9
§
○
>*%7DE9%#3%6)+25%0)%$)74&'L%).%6.),'2%5)@2?%1'0%.'5+$0#)2%)*%-$0#(#0/%6/%
1'2'%0"-0%%'2$)5'3%#0
○
J
Eukaryotic+Gene+Regulation+II
W.#5-/?%94.#&%P_?%P_^o ^P[_P%Sg
Unlock document

This preview shows pages 1-3 of the document.
Unlock all 11 pages and 3 million more documents.

Already have an account? Log in

Document Summary

E) feedback control translational control transcriptional control posttranscriptional control posttranslational control. If you add a negatively charged phosphate, adding something with charge changes its shape and function. Chromatin must be drastically remodeled around a target gene to allow transcription. If it is open and loosely compacted, rna polymerase can bind to the promoter and drive transcription. X-chromosomes addition of methyl groups can cause compaction. To regulate the activity of subsets of genes is acetylation. Increases repulsion of the molecules so it doesn"t stay compact. Histone deacetylases (hdacs) remove acetyl groups from histones and allow chromatin condensation and is associated with gene deactivation. Histone acetyl transferases (hats) add negatively charged acetyl groups to positively charged histone lysine residues resulting in chromatin de- condensation and allowing gene expression. condensation and allowing gene expression. Chemical modifications on histones varies between cell types and is heritable. Acetylation is an e. g. of epigenetic inheritance, inheritance not due to differences in gene sequences.

Get access

Grade+20% off
$8 USD/m$10 USD/m
Billed $96 USD annually
Grade+
Homework Help
Study Guides
Textbook Solutions
Class Notes
Textbook Notes
Booster Class
40 Verified Answers
Class+
$8 USD/m
Billed $96 USD annually
Class+
Homework Help
Study Guides
Textbook Solutions
Class Notes
Textbook Notes
Booster Class
30 Verified Answers

Related Documents

BIOL 142 Lecture 28: Cell Signaling
bluemosquito338
BIOL 142 Chapter Notes - Chapter 19.5-19.6: Rna Interference, Alternative Splicing, Chromatin
bluemosquito338
BIOL 142 Chapter Notes - Chapter 19.1: Chromatin Remodeling, Chromatin, Euchromatin
bluemosquito338

Related Questions

Question 1

Not yet answered

Marked out of 1.00

Flag question

Question text

The function of tRNA is to

Select one:

a. provide a site for polypeptide synthesis

b. transport amino acids to the ribosome

c. transcribe DNA

d. transform DNA

Question 2

Not yet answered

Marked out of 1.00

Flag question

Question text

The lipid bi-layer is

Select one:

a. hydrophilic

b. hydrophobic

c. hydrophilic and hydrophobic

d. depends on the surrounding medium

Question 3

Not yet answered

Marked out of 1.00

Flag question

Question text

Which of the following statements is FALSE?

Select one:

a. carbohydrates are generally hydrophilic molecules.

b. living things use carbohydrates for structure and for energy storage.

c. carbohydrates are composed principally of carbon, hydrogen, and oxygen.

d. none of the above – they are all true

Question 4

Not yet answered

Marked out of 1.00

Flag question

Question text

Which of the following terms correctly describes a compound featuring more than one double bond?

Select one:

a. saturated

b. polyunsaturated

c. monounsaturated

d. disaturated

Question 5

Not yet answered

Marked out of 1.00

Flag question

Question text

Eukaryotic mRNA transcripts are protected from modification by

Select one:

a. 5' caps

b. 5' poly-A caps

c. 3' caps

d. 5'-3' poly tails

Question 6

Not yet answered

Marked out of 1.00

Flag question

Question text

The methods of membrane transport that don't require protein channels or carriers are

Select one:

a. osmosis

b. diffusion

c. phagocytosis

d. exocytosis

e. all of the above

Question 7

Not yet answered

Marked out of 1.00

Flag question

Question text

Complete the following sentences: "Primary active transport is dependent on __________. Secondary active transport is dependent on __________ created by __________.

Select one:

a. channel proteins, electrochemical gradient, carrier proteins

b. electrochemical gradient, ATP, mitochondria

c. electrochemical gradient, ATP, primary active transport

d. ATP, electrochemical gradient, primary active transport

e. carrier proteins, electrochemical gradient, channel protein

Question 8

Not yet answered

Marked out of 1.00

Flag question

Question text

Which of the following is a reduced compound?

Select one:

a. CO2

b. O2

c. N2

d. NAD +

e. NADH

Question 9

Not yet answered

Marked out of 1.00

Flag question

Question text

Gel electrophoresis separates DNA fragments according to their:

Select one:

a. base sequence

b. size

c. percentage of labelled nucleotides

d. electrical charge

Question 10

Not yet answered

Marked out of 1.00

Flag question

Question text

G0 is:

Select one:

a. part of interphase

b. the phase of the cell cycle where DNA replication occurs

c. the phase of the cell cycle where two identical daughter cells are created

d. a special "resting" phase in which cells are in a non cycling state

e. a special phase where the number of chromosomes in a parent cell is reduced by half such that each daughter cell contains only one member of a pair of homologous chromosomes

Question 11

Not yet answered

Marked out of 1.00

Flag question

Question text

At which pH will the concentration of hydrogen ions be equal to the concentration of hydroxide ions?

Select one:

a. pH 1

b. pH 5

c. pH 7

d. pH 9

e. pH 14

Question 12

Not yet answered

Marked out of 1.00

Flag question

Question text

Which of the following enzymes has proofreading activity?

Select one:

a. Ligase

b. Helicase

c. Topoisomerase

d. DNA polymerase

e. Peptidyl transferase

Question 13

Not yet answered

Marked out of 1.00

Flag question

Question text

The process of _______________ cuts introns from the primary transcript and the final "processed" mRNA is produced.

Select one:

a. RNA cleaving

b. RNA translocation

c. RNA elongation

d. RNA splicing

Question 14

Not yet answered

Marked out of 1.00

Flag question

Question text

Transcription is initiated when RNA polymerase binds to

Select one:

a. a promoter

b. an initiator

c. a transciptor

d. a codon

Question 15

Not yet answered

Marked out of 1.00

Flag question

Question text

Complete the following sentences: "__________ connect the extracellular matrix with microfilaments. __________ connect intermediate filaments from adjacent cells."

Select one:

a. Cadherins, Integrins

b. Connexins, Cadherins

c. Integrins, Cadherins

d. Integrins, Connexins

e. Connexins, Integrins

Question 16

Not yet answered

Marked out of 1.00

Flag question

Question text

Which of the following regions of RNAs are translated?

Select one:

a. 5' UTR

b. exons

c. introns

d. 3' UTR

e. poly-A

Question 17

Not yet answered

Marked out of 1.00

Flag question

Question text

Control of gene expression in eukaryotic cells occurs at which level(s)?

Select one:

a. only the transcriptional level

b. epigenetic and transcriptional levels

c. epigenetic, transcriptional, and translational levels

d. epigenetic, transcriptional, posttranscriptional, translational, and posttranslational levels

Question 18

Not yet answered

Marked out of 1.00

Flag question

Question text

Cellular organelles containing hydrolytic enzymes are called:

Select one:

a. peroxisomes

b. lysosomes

c. ribosomes

d. mesosomes

Question 19

Not yet answered

Marked out of 1.00

Flag question

Question text

______ are chemicals or combinations of chemicals that take up excess hydrogen ions or hydroxide ions in order to keep the pH constant.

Select one:

a. acids

b. bases

c. salts

d. buffers

e. carbohydrates

Question 20

Not yet answered

Marked out of 1.00

Flag question

Question text

Which of the following proteins appear in some stages of the cell cycle and are degraded at other stages?

Select one:

a. kinases

b. cyclins

c. nucleotides

d. phosphatases

e. none of the above

Question 21

Not yet answered

Marked out of 1.00

Flag question

Question text

Which of the following correctly matches an organelle with its function?

Select one:

a. mitochondrion photosynthesis

b. nucleus cellular respiration

c. ribosome manufacture of lipids

d. lysosome movement

e. central vacuole storage

Question 22

Not yet answered

Marked out of 1.00

Flag question

Question text

What is the sequence corresponding to the following electropherogram obtained by Sanger sequencing (green: A; red:T; black: G; blue: C)?

Select one:

a. CCGTTATGAAC

b. GGCTTATGAAG

c. CAACTATTGCC

d. GGCAATAGTTG

e. CCGTTATCAAC

Question 23

Not yet answered

Marked out of 1.00

Flag question

Question text

Which of the following statement is true

Select one:

a. the two DNA strands are parallel and complementary

b. the two DNA strands are anti parallel and non-complementary

c. the two DNA strands are anti-parallel and complementary

d. none of these

Question 24

Not yet answered

Marked out of 1.00

Flag question

Question text

The energy-requiring process by which small molecules are joined to form larger molecules is specifically called

Select one:

a. metabolism

b. anabolism

c. catabolism

d. enzymatic reactions

Question 25

Not yet answered

Marked out of 1.00

Flag question

Question text

When DNA replication starts

Select one:

a. the phosphodiester bonds between the adjacent nucleotides break

b. the bonds between the nitrogen base and deoxyribose sugar break

c. the leading strand produces Okazaki fragments

d. the hydrogen bonds between the nucleotides of two strand break

Question 26

Not yet answered

Marked out of 1.00

Flag question

Question text

A(n)_______ is the movement of a segment of a chromosome from one chromosome to another nonhomologous chromosome

Select one:

a. inversion

b. translocation

c. deletion

d. duplication

Question 27

Not yet answered

Marked out of 1.00

Flag question

Question text

Complete the following sentences: "Replication forks from the same origin of replication extend __________. __________ DNA strand is used as template for the leading strand at one fork and for the lagging strand at the second fork. New DNA is synthesized from 5' to 3' on the __________."

Select one:

a. unidirectionally, A different, both the leading and lagging strands

b. bidirectionally, The same, leading strand

c. bidirectionally, The same, lagging strand

d. unidirectionally, A different, leading strand

e. bidirectionally, The same, both the leading and lagging strands

Question 28

Not yet answered

Marked out of 1.00

Flag question

Question text

Manufacturing recombinant DNA molecules involves cutting a gene from its normal location, inserting it into a circular piece of DNA from a bacterial cell, and then transferring the circle of DNA to cells of another species. Which of the below describe the circular piece of DNA?

Select one:

a. restriction enzyme

b. plasmid

c. bacteriophage

d. transposon

Question 29

Not yet answered

Marked out of 1.00

Flag question

Question text

Complete the following chemical equation to make it balanced: glycerol + ___ ? triacylglycerol + ___

Select one:

a. 3 fatty acid, 3 H2O

b. fatty acid, H2O

c. 3 OH-, 3 H+

d. 3 H2O, 3 fatty acid

e. fatty acid, 3 H2O

Question 30

Not yet answered

Marked out of 1.00

Flag question

Question text

Which structure is found in plant cells but not animal cells? Check all that apply.

Select one or more:

a. Cell wall

b. Chloroplast

c. Plastid

d. Central vacuole

e. Lysosomes